EUVIMEDEUVIMED entdecken
Crossref

Nationwide utilization of antidepressants and anxiolytics during pandemic restrictions: results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study

Caner Vizdiklar iD, Volkan Aydin iD, Hakan Yilmaz iD, Ahmet Akici iD

Family Practice · 14.08.2025 · 42 (5)

DOI: 10.1093/fampra/cmaf072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Family Practice, online erschienen am 26.08.2025. Verfasst von Caner Vizdiklar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Marmara University School of Medicine, Istanbul 34854, Turkey. Hauptthemen laut MEDLINE: Anti-Anxiety Agents, Antidepressive Agents, COVID-19, Drug Utilization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Health Institutes of Turkey.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The prevalence of mental health disorders rose when the impact of the COVID-19 pandemic was most pronounced, potentially altering the consumption of antidepressants and anxiolytics. We aimed to evaluate changes in antidepressant and anxiolytic utilization throughout the COVID-19 pandemic era.

Methods

Nationwide drug sales and prescribing data through 01.03.2018–31.12.2022 were sourced from IQVIA Turkey. We assessed mean monthly consumption and expenditure trends of antidepressants and anxiolytics, along with quarterly prescribing levels, across three periods: “before restrictions” (BfR, 01.03.2018–31.03.2020), “during restrictions” (DuR, 01.04.2020–31.03.2022), and “after restrictions” (AfR, 01.04.2022–31.12.2022), using “defined daily dose per 1000 inhabitants per day” (DID) measure.

Results

Antidepressant consumption escalated from 47.9 ± 4.3 DID in BfR to 56.2 ± 8.9 DID in DuR (P < .001), reaching 60.5 ± 8.9 DID in AfR (P < .001 vs. BfR). Anxiolytic use increased from 2.0 ± 0.3 DID in BfR to 2.5 ± 0.3 DID in DuR (P < .001), and to 2.7 ± 0.3 DID in AfR (P < .001 vs. BfR). Expenditure also rose in DuR and AfR for both drug groups (P < .01). Prescribing trends for antidepressants decreased in DuR (P < .001) and showed an insignificant rebound in AfR (P > .05 vs. BfR and DuR), while anxiolytic prescribing surged in DuR (P = .001 vs. BfR) and subsequently reverted in AfR (P > .05 vs. BfR and DuR). These patterns were consistent across both new and ongoing users.

Conclusions

This study showed a sustained increase in the use of antidepressants and anxiolytics following the onset of pandemic despite fluctuations in prescribing, implying a heightened need for pharmacotherapy and greater burden of depressive and anxiety disorders, especially for the latter.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Anxiety AgentsAntidepressive AgentsCOVID-19Drug UtilizationPractice Patterns, Physicians'DepressionHumansTurkeySARS-CoV-2PandemicsMale

Stichwörter der Autor:innen

COVID-19 pandemicanxiety disordersdrug utilizationmood disorders

Substanzen

Anti-Anxiety AgentsAntidepressive Agents

Autor:innen und Institutionen

  • Department of Medical Pharmacology, Marmara University School of Medicine, Istanbul 34854, Turkey.
  • Department of Clinical Trials, Turkish Medicines and Medical Devices Agency, Ankara 06520, Turkey.
  • Department of Basic Medical Sciences/Pharmacology, Marmara University School of Dentistry, Istanbul 34854, Turkey.
  • Marmara University Institute of Health Sciences, Istanbul 34865, Turkey.
  • Department of Psychiatry, Antalya Training and Research Hospital, Antalya 07100, Turkey.

ORCID-Profile: Caner Vizdiklar, Volkan Aydin, Hakan Yilmaz, Ahmet Akici

Förderung

  • Health Institutes of Turkey

Zitieren

APA

Vizdiklar, C., Aydin, V., Yilmaz, H., & Akici, A. (2025). Nationwide utilization of antidepressants and anxiolytics during pandemic restrictions: results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study. Family Practice, 42(5). https://doi.org/10.1093/fampra/cmaf072

Vancouver

Vizdiklar C, Aydin V, Yilmaz H, Akici A. Nationwide utilization of antidepressants and anxiolytics during pandemic restrictions: results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study. Family Practice. 2025;42(5). doi:10.1093/fampra/cmaf072

BibTeX
@article{Vizdiklar2025,
  author = {Vizdiklar, Caner and Aydin, Volkan and Yilmaz, Hakan and Akici, Ahmet},
  title = {Nationwide utilization of antidepressants and anxiolytics during pandemic restrictions: results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study},
  journal = {Family Practice},
  year = {2025},
  volume = {42},
  number = {5},
  doi = {10.1093/fampra/cmaf072}
}
Kostenlos starten →